This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
PR Conlin , D Chow , ER Miller 3rd LP Svetkey , PH Lin , DW Harsha , TJ Moore , FM Sacks & LJ Appel (2000) The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertension 13, 949–955.
RK Ferguson , PH Vlasses , JR Koplin , A Shirinian , JF Burke Jr & JC Alexande (1980) Captopril in severe treatment-resistant hypertension. Am Heart J 99, 579–585.
T Kawasaki , E Seki , K Osajima , M Yoshida , K Asada , T Matsui & Y Osajima (2000) Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 14, 519–523.
M Maeno , N Yamamoto & T Takano (1996) Identification of an antihypertensive peptide from casein hydrolyzate by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 79, 1316–1321.
S Maruyama , K Nakagomi , N Tomizuka & H Suzuki (1985) Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileum of rats. Agric Biol Chem 49, 1405–1409.
N Matsumura , M Fujii , Y Takeda , K Sugita & T Shimizu (1993) Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 57, 695–697.
H Meisel & W Bockelmann (1999) Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie van Leewenhoek 76, 207–215.
S Miyoshi , H Ishikawa , T Kaneko , F Fukui , H Tanaka & S Maruyama (1991) Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agric Biol Chem 55, 1313–1318.
S Mizuno , S Nishimura , K Matsuura , T Gotou & N Yamamoto (2004) Release of short and proline rich antihypertensive peptides from casein hydrolyzate with an Aspergillus oryzae protease. J Dairy Sci 87, 3183–3188.
TJ Moore , WM Vollmer , LJ Appel , (1999) Effect of dietary patters on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) trial: DASH collaborative research group. Hypertension 34, 472–477.
Y Nakamura , O Masuda & T Takano (1996) Decrease of tissue angiotensinI-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotech Biochem 60, 488–489.
Y Nakamura , N Yamamoto , K Sakai , A Okubo , S Yamazaki & T Takano (1995a) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78, 777–783.
J Staessen (1981) The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin-angiotensin-aldosterone system. Clin Sci 61, 441–444.
M Stornello , G Di Rao , M Iachello , (1983) Hemodynamic and humoral interactions between captopril and nifedipine. Hypertension 5, 154–156.
LP Svetkey , TJ Moore , DG Simons-Morton , (2001) DASH collaborative research group Angiotensinogen genotype and blood pressure response in the dietary approaches to top hypertension (DASH) study. J Hypertens 19, 1949–1956.
T Takano (1998) Milk derived peptides and hypertension reduction. Int Dairy J 8, 375–381.
N Yamamoto , A Akino & T Takano (1994) Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci Biotech Biochem 58, 776–778.
N Yamamoto , M Ejiri & S Mizuno (2003) Biogenic peptides and their potential use. Curr Pharmaceut Design 9, 1345–1355.
N Yamamoto & T Takano (1999) Antihypertensive peptides derived from milk proteins. Nahrung 43, 159–164.
N Yamamoto , M Maeno & T Takano (1999) Purification of the antihypertensive peptide from yogurt-like product. J Dairy Sci 82, 1388–1393.
K Yokoyama , H Chiba & M Yoshikawa (1992) Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci Biotechnol Biochem 56, 1541–1545.